EMILY BURGER: Open Payments
NPI 1508143546 · WIGGINS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 51 payments from 17 companies in 2025. Trend: 2023 $1,384 · 2024 $1,428 · 2025 $924
Food & beverage: $881Education: $43
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $181 |
| Novartis Pharmaceuticals Corporation | 14 | $153 |
| E.R. Squibb & Sons, L.L.C. | 4 | $95 |
| Janssen Biotech, Inc. | 3 | $80 |
| UCB, Inc. | 3 | $62 |
| Galderma Laboratories, L.P. | 3 | $58 |
| ABBVIE INC. | 3 | $55 |
| PFIZER INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| LEO Pharma Inc. | 1 | $29 |
Products named: DUPIXENT, COSENTYX, Sotyktu, TREMFYA, Bimzelx, EBGLYSS, NEMLUVIO, ADBRY.
Industry payments across MS — which companies pay providers there.
